This message was sent to ##Email##
|
| January 9, 2019 |
| |  | | |
|
|
|
| |
Reuters Health via Medscape (free login required)
The presence of human papillomavirus subtypes HPV-16 and HPV-18 in women negative for intraepithelial lesions or malignancy is associated with an increased risk of developing high-grade cervical intraepithelial neoplasia, according to new research from Sweden. "These findings, along with others, strongly indicate that testing for HPV should be incorporated into cervical-cancer screening programs," Dr. Karen Belkic from Karolinska University Hospital and Institute, in Stockholm, told Reuters Health by email. "Physicians should not rely solely upon normal cervical cytology findings in judging their patients' risk of developing high-grade CIN. Testing for HPV and especially HPV-16 or HPV-18 is essential."
READ MORE
ASCT
ASCT is pleased to announce the Bob Gay Student Scholarship for Cytotechnology students is being offered for the fifth year in a row to deserving students with a record of academic achievement. The scholarship was created in honor and memory of Robert “Bob” Gay, who was a long-time supporter and founding member of the ASCT. Last year, for the first time, we awarded two scholarships. We will do the same this year.
For more information, the application, and requirements, visit www.asctservices.com. The winners will be announced at the annual conference in San Juan, Puerto Rico.
| Date |
Event |
Location |
More information |
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
May 3 - 5, 2019 |
2019 ASCT Annual Conference
|
San Juan, Puerto Rico |
Details |
WCAV-TV
Scientists understand how HPV causes cancers by producing a protein that shuts down a healthy cell's ability to prevent them, but efforts to block one of those proteins, called oncoprotein E6, have so far proven unsuccessful. Now, researchers at the University of Virginia say they have found the virus takes the help of a protein already present in human cells, an enzyme called USP46, which then become essential for HPV-induced tumor formation. The researchers add that the enzyme could be very susceptible to drugs.
READ MORE
Medical Xpress
A new test for cervical cancer was found to detect all of the cancers in a randomized clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus test at a reduced cost, according to a study led by Queen Mary University of London. As opposed to checking for patterns in the DNA genetic code itself that are indicative of the HPV virus, the new test looks at the naturally-occurring chemical markers that appear on top of the DNA, making up its "epigenetic profile."
READ MORE
PharmaTimes Online
Researchers from Cardiff University have discovered a protein driving aggressive breast cancer, which they say could be targeted for developing new and improved therapies.
READ MORE
NPR
New research shows that cancer patients who are single receive less aggressive treatment than those who are married. NPR's Michel Martin talks with researcher Joan DelFattore about her findings.
READ MORE
Forbes
Nowadays 'liquid biopsies,' the notion of detecting cancer using only a blood test to detect minute amounts of circulating tumor are fairly well-known. But what if not even a blood test was needed to detect cancer, merely a few lungfuls of air?
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
